[1]
Salem, I.A. et al. 2023. Evaluation of Neopterin as a Neuroinflammatory Marker for Peripheral Neuropathy in Type 2 Diabetic Patients. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 5, 1S (Dec. 2023), S183–188. DOI:https://doi.org/10.54133/ajms.v5i1S.397.